Industry updates and clinical trial data at the upcoming 2025 ARVO Annual Meeting
Therapies for retinal vascular disease, dry eye disease, inflammation following glaucoma filtration surgery and more
Eyestem Research announces positive results from phase 1 geographic atrophy trial
Bangalore-based Eyestem will share more research findings on Eyecyte-RPE at this year's Association for Research in Vision and Ophthalmology meeting
ARVO 2024: Trial design and increased accuracy of meibomian gland morphology measurements
At the 2024 ARVO meeting, Andrew D. Pucker, OD, PhD, presented a paper on measuring meibomian gland morphology
ARVO 2024: Mutation agnostic optogenetic programme demonstrates possible treatment for patients with severe retinal degeneration
Allen Ho, MD, presented on the 12-month results of an mutation agnostic optogenetic programme at the ARVO 2024 meeting
